PUB - Publikationen an der Universität Bielefeld

Schlotawa, L., Kettwig, M., Ahrens-Nicklas, R., Baud, M., Brunetti-Pierri, N., Gagne, A., Schroeder, S., et al. (2023). Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency. Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions, Molecular Genetics and Metabolism, 138, 117-118. San Diego: Elsevier. https://doi.org/10.1016/j.ymgme.2022.107308

Schlotawa, L., Kettwig, M., Ahrens-Nicklas, R., Baud, M., Brunetti-Pierri, N., Gagne, A., Schroeder, S., Monfregula, J., Pena, T., Radhakrishnan, K., et al. (2023). “Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency” in Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions Molecular Genetics and Metabolism, vol. 138, (San Diego: Elsevier), 117-118.

Schlotawa, L., et al., 2023. Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency. In Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions. Molecular Genetics and Metabolism. no.138 San Diego: Elsevier, pp. 117-118.

L. Schlotawa, et al., “Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency”, Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions, Molecular Genetics and Metabolism, vol. 138, San Diego: Elsevier, 2023, pp.117-118.

Schlotawa, L., Kettwig, M., Ahrens-Nicklas, R., Baud, M., Brunetti-Pierri, N., Gagne, A., Schroeder, S., Monfregula, J., Pena, T., Radhakrishnan, K., Waxman, E.A., Fischer, A., French, D.L., Gelb, M.H., Gaertner, J.: Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency. Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions. Molecular Genetics and Metabolism. 138, p. 117-118. Elsevier, San Diego (2023).

Schlotawa, Lars, Kettwig, Matthias, Ahrens-Nicklas, Rebecca, Baud, Matthias, Brunetti-Pierri, Nicola, Gagne, Alyssa, Schroeder, Sophie, Monfregula, Jilenia, Pena, Tonatiuh, Radhakrishnan, Karthikeyan, Waxman, Elisa A., Fischer, Andre, French, Deborah L., Gelb, Michael H., and Gaertner, Jutta. “Screening of approved drugs identifies 3rd generation retinoids as in vitro therapeutic agents in multiple sulfatase deficiency”. Program and Abstracts WORLDSymposiumTM 2023* 19th Annual Research Meeting & Scientific Sessions. San Diego: Elsevier, 2023.Vol. 138. Molecular Genetics and Metabolism. 117-118.